Is MSAC or ABBV a better dividend investment in 2026?

MSAC currently yields 19.67% with a 5% 5-year dividend growth rate. ABBV yields 3.67% with 8.9% growth. The better choice depends on your goal: MSAC offers higher current income.

What is the dividend yield difference between MSAC and ABBV?

MSAC has a forward dividend yield of 19.67% ($2.00/share annually). ABBV yields 3.67% ($6.20/share annually). The yield gap is 16.00 percentage points.

Home › Compare › MSAC vs ABBV

MSAC vs ABBV: Dividend Comparison 2026

MSAC yields 19.67% · ABBV yields 3.67%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MSAC wins by $31.6K in total portfolio value

INVESTMENT

TIME HORIZON10 years

MSAC

● Live price

19.67%

Share price

$10.17

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$71.5K

Annual income

$6,501.71

Full MSAC calculator →

ABBV

AbbVie Inc.

● Live price

3.67%

Share price

$168.90

Annual div

$6.20

5Y div CAGR

8.9%

Payout ratio

58%

After 10 yrs · $10,000 · DRIP

Portfolio value

$39.9K

Annual income

$1,154.43

Full ABBV calculator →

Portfolio growth — MSAC vs ABBV

📍 MSAC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MSAC	ABBV
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MSAC + ABBV cover 4 of 12 months — good coverage

Jan

ABBV

Feb

—

Mar

—

Apr

ABBV

May

—

Jun

—

Jul

ABBV

Aug

—

Sep

—

Oct

ABBV

Nov

—

Dec

—

MSAC pays

ABBV pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MSAC

Annual income on $10K today (after 15% tax)

$1,671.58/yr

After 10yr DRIP, annual income (after tax)

$5,526.45/yr

ABBV

Annual income on $10K today (after 15% tax)

$312.02/yr

After 10yr DRIP, annual income (after tax)

$981.27/yr

At 15% tax rate, MSAC beats the other by $4,545.19/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MSAC + ABBV for your $10,000?

MSAC: 50%ABBV: 50%

100% ABBV50/50100% MSAC

Portfolio after 10yr

$55.7K

Annual income

$3,828.07/yr

Blended yield

6.87%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

MSAC

No analyst data

ABBV

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$256.15

+51.7% upside vs current

Range: $223.00 — $299.00

Altman Z

2.0

Piotroski

8/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MSAC buys

ABBV buys

No recent congressional trades found for MSAC or ABBV in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMSACABBV

Forward yield	19.67% ✓	3.67%
Annual dividend / share	$2.00	$6.20 ✓
Payout ratio	50% ✓	58%
1-year div growth	0%	4.7% ✓
5-year div CAGR	0%	8.9% ✓
Portfolio after 10y	$71.5K ✓	$39.9K
Annual income after 10y	$6,501.71 ✓	$1,154.43
Total dividends collected	$40.3K ✓	$7.2K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: MSAC vs ABBV ($10,000, DRIP)

Year	MSAC Portfolio	MSAC Income/yr	ABBV Portfolio	ABBV Income/yr	Gap
1← crossover	$12,667	$1,966.57	$11,520	$399.75	+$1.1K → MSAC
2	$15,881	$2,328.01	$13,261	$450.98	+$2.6K → MSAC
3	$19,721	$2,727.88	$15,255	$508.41	+$4.5K → MSAC
4	$24,267	$3,165.79	$17,536	$572.74	+$6.7K → MSAC
5	$29,606	$3,640.75	$20,145	$644.78	+$9.5K → MSAC
6	$35,830	$4,151.23	$23,126	$725.38	+$12.7K → MSAC
7	$43,034	$4,695.21	$26,532	$815.52	+$16.5K → MSAC
8	$51,316	$5,270.23	$30,420	$916.26	+$20.9K → MSAC
9	$60,782	$5,873.44	$34,855	$1,028.80	+$25.9K → MSAC
10	$71,538	$6,501.71	$39,914	$1,154.43	+$31.6K → MSAC

MSAC vs ABBV: Complete Analysis 2026

MSAC — Stock

Medicus Sciences Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on the healthcare industry primarily the medical technology sector in the United States and internationally. The company was incorporated in 2020 and is based in New York, New York.

Full MSAC Calculator →

ABBV — Healthcare

AbbVie is a pharmaceutical giant best known for Humira and newer blockbusters Skyrizi and Rinvoq. A Dividend Aristocrat with 52+ years of consecutive dividend increases. Strong free cash flow generation supports its above-average yield. The company's diversified pipeline reduces dependence on any single drug.

Full ABBV Calculator →

📬

Get this MSAC vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MSAC vs SCHD MSAC vs JEPI MSAC vs O MSAC vs KO MSAC vs MAIN MSAC vs JNJ MSAC vs MRK MSAC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.